0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0,51
0,00%
(0,00) 1 HR
16 Okt, 16.08.14 GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 0775...
Pembukaan
HK$0,51
Tinggi
HK$0,52
Rendah
HK$0,51
Kapitalisasi pasar
4,90 M
Volume rata-rata
1,66 jt
Volume
956,00 rb
Harga tinggi dalam 52 minggu terakhir
HK$1,02
Harga rendah dalam 52 minggu terakhir
HK$0,51
EPS
-HK$0,01
Saham beredar
9,61 M
Jumlah karyawan
2 rb
Pembukaan
HK$0,51
Tinggi
HK$0,52
Rendah
HK$0,51
Kapitalisasi pasar
4,90 M
Volume rata-rata
1,66 jt
Volume
956,00 rb
Harga tinggi dalam 52 minggu terakhir
HK$1,02
Harga rendah dalam 52 minggu terakhir
HK$0,51
EPS
-HK$0,01
Saham beredar
9,61 M
Jumlah karyawan
2 rb
Artikel berita
Dari sumber web dan partner berita
Vietnam.vn
·
20 jam yang lalu
Indeks S&P 500 mengalami penurunan mingguan paling tajam sejak Juni 2026.
Pluang
·
20 jam yang lalu
Bitcoin bisa turun ke $10.000 jika S&P 500 jatu...
XTB.com
·
2 hari yang lalu
Dow Jones Naik 1%, Yield Treasury AS Turun ke 5,1%
XTB.com
·
1 hari yang lalu
Dow Jones Naik, Nasdaq dan Saham AI Turun
Profil
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Tentang CK Life Sciences Intl (Holdings) Inc